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Although oral bacteria-associated systemic diseases have been reported, association between Streptococcus
mutans, pathogen of dental caries, and ulcerative colitis (UC) has not been reported. We investigated the
effect of various S. mutans strains on dextran sodium sulfate (DSS)-induced mouse colitis. Administration
of TW295, the specific strain of S. mutans, caused aggravation of colitis; the standard strain, MT8148 did
not. Localization of TW295 in hepatocytes in liver was observed. Increased expression of interferon-c in
liver was also noted, indicating that the liver is target organ for the specific strain of S. mutans-mediated
aggravation ofcolitis.ThedetectionfrequencyofthespecificstrainsinUCpatientswassignificantlyhigher
than in healthy subjects. Administration of the specific strains of S. mutans isolated from patients caused
aggravation of colitis. Infection with highly-virulent specific types of S. mutans might be a potential risk
factor in the aggravation of UC.
U
lcerative colitis (UC) and Crohn's disease (CD), major inflammatory bowel diseases (IBDs), are chronic,
relapsingenteropathiesofunknownorigin
1–4.Remissionandrelapses,withsymptomsofbloodydiarrhea,
abdominal pain, and bleeding, characterize these diseases. Recently, the incidence of IBDs has increased
globally
5. Although the pathogenesis is likely dependent on the interaction between local immune reactions and
environmental factors in genetically susceptible individuals, the etiology of IBDs is still unknown
1–5. Current
theories also suggest that a dysregulated mucosal immune response to unidentified components of normal
intestinal microbiota in a genetically susceptible host is at the core of these diseases
6–8. Therefore, involvement
of intestinal bacteria is considered an important factor in the onset of IBD. In fact, administration of antibiotics
sometimesshowstheameliorationofIBDsymptomsinpatients
9.However,otherbacterialassociationsonaccess
routes into local bowel areas have not been investigated.
Recently, oral bacteria-associated systemic diseases have received increasing attention
10–14. Although there are
richmicrovesselsinthedentalmucosa,itdoesnothavewell-developedsystematicandstrictimmunesystemslike
the intestinal mucosa. Therefore, oral bacteria are considered capable of invading the blood circulation,resulting
in bacteremia and other systemic diseases. Previous reports also indicate that bacteremia is associated with such
dental procedures astooth brushing and extraction
15,16.Therefore, it shouldbe considered thatthe mucosa in the
dental pocket is an important access route for bacteria invading the blood circulation.
In general, pathogenic oral bacteria are classified into two major groups; one is the pathogen for dental caries,
and the other is for periodontitis. Streptococcus mutans (S. mutans), a major pathogen of dental caries, is also
known to be a causative agent of infective endocarditis. Recently, we reported the isolation of several specific
strains of S. mutans; we confirmed that such strains had different serotypes from that of standard strain,
MT8148
17–19. Most of these specific types of S. mutans belong to minor serotypes k or f. Serotype k was isolated
from the blood of patients with bacteremia after tooth extraction or infective endocarditis
17–19. S. mutans is
SUBJECT AREAS:
MICROBIOLOGY
DISEASES
IMMUNITY
MEDICAL RESEARCH
Received
3 January 2012
Accepted
13 February 2012
Published
26 March 2012
Correspondence and
requests for materials
should be addressed to
K.W. (kwada@ dent.
osaka-u.ac.jp)
SCIENTIFIC REPORTS | 2 : 332 | DOI: 10.1038/srep00332 1classified into four serotypes (c/e/f/k): in the oral cavity of healthy
subjects,serotypechasaprevalenceofover70%;serotypeeaccounts
for approximately 20%; serotype f and k strains amount to less than
5%
17–19. Thus, S. mutans has been identified as a possible pathogen
not only for dental caries but also such systemic diseases as bacter-
emiaandinfective endocarditis. However,the associationbetween S.
mutans and other systemic diseases has not been elucidated.
Interestingly, we have recently found that the specific strains of
S. mutans caused hemorrhagic damages in the murine brain and
other tissues
20,21. In those studies, we reported that the specific
strains of S. mutans that express collagen-binding protein (CBP)
and are serotype k (or f) caused hemorrhagic stroke because of the
ability to bind the collagen and resistance to phagocytosis
21.
Therefore, we concluded that CBP-expressing and serotype k (or
f) strains of S. mutans are highly virulent in hemorrhagic and
inflammatory diseases. In fact, such highly virulent strains of S.
mutans specifically caused serious damages on potentially injured
or weakened parts. Therefore, it is considered that transient bac-
teremia of such highly virulent strains of S. mutans may cause the
aggravation of ulcerative colitis if subjects have a potential damage
or inflammation on colon. In addition, in our preliminary screen-
ing study, we found that the detection frequency of the specific
strains of S. mutans was comparatively higher in UC patients than
in healthy subjects. Thus, we speculate that such specific strains of
S. mutans may be involved in the pathogenesis of UC. In the
present study, we show that infection by the specific strains of
S. mutans is a potential risk factor for the aggravation of ulcerative
colitis. Our data presents a concept for new potential risk factors
for UC.
Results
Aggravation of mouse colitis by TW295, a specific strain of S.
mutans. Symptoms of IBD in DSS-induced colitis began 4 days
after the mice started drinking water containing DSS. Therefore,
we administered the bacteria to the mice on day 4 (Fig. 1a).
Intravenous administration of TW295, a serotype k strain of S.
mutans, showed an increase in the disease activity index (DAI),
which indicates the severity of colitis, in DSS-induced colitis mice
comparedwithcontrolsonday10(Fig.1b).Atendencyforincreased
body weight loss in TW295-infected mice was also observed
(Supplementary Fig. S1). Interestingly, a marked decrease in the
survival rate of TW295-infected mice was observed compared with
controls (Fig. 1c, d). Obvious alterations of the whole animal and the
colon in TW295-infected mice were already evident on day 10
(Fig. 1e). Mucosal damage and infiltration of inflammatory cells
were microscopically observed in TW295-infected mice (Fig. 1f).
In contrast, administration of MT8148, a serotype c standard
strain of S. mutans, did not produce any aggravation of the colitis
symptoms (Fig. 1b, c, d). These results clearly indicate that only the
specific strain of TW295, the serotype k strain, could aggravate the
inflammation of DSS-induced mouse colitis.
Next, we conducted the dose-dependency investigation of how
many bacterial cells were required to cause the TW295-mediated
aggravation of colitis. The increase in DAI and decrease in survival
ratebyTW295wereobservedwiththeadministrationof10
5bacterial
cells(Fig.1g,h).Sincesuchbacterialcellnumbersinvadingtheblood
circulationareconsideredeasilyachievablewithdentalprocedures
15,
transient bacteremia may be involved in the aggravation of colitis in
clinical situations. We also investigated the route-dependency of
TW295-induced aggravation of colitis. Even the oral administration
ofmorethan10
8TW295cellsdidnotproduceanyaggravationofthe
colitissymptoms(Fig.1i).Theseresultsclearlyindicatethattheroute
the TW295-mediated aggravation of colitis in the intestinal mucosa
is through the blood circulation, not from the mucosal lumen side of
the gastrointestinal tract.
Target organs of TW295-induced aggravation of colitis. To
investigate the target organs causing the TW295-induced
aggravation of colitis, we initially tried to detect the invading
bacteria in the gastrointestinal tract. However, we could not detect
the invading bacteria either in the colon or small intestine (Fig. 2a).
Surprisingly, the administered TW295 was specifically localized in
the liver. The invaded TW295 was still surviving, which we
confirmed by the recovery of living TW295 in liver homogenate
(Fig. 2b). In addition, we checked the time-course of TW295
localization in the liver and discovered that the peak of maximum
localizedtimewas180 minafteradministration(Fig.2c).Incontrast,
MT8148, the standard strain of S. mutans, was scarcely localized in
the liver. These results indicate that the localization of administered
bacteriaintheliverisspecificforTW295,butnotthestandardstrain
of S. mutans.
To investigate where the invading were localized in the liver,
immunohistochemical staining of serotype k strain using anti-
serotypekantibodywasperformed.AsshowninFig.2d,localization
of serotype k strain was observed in hepatocytes. In addition, we
prepared green fluorescent protein (GFP)-expressing TW295 and
used it to confirm the localization in hepatocytes. We observed
uptake of administered GFP-expressing TW295 by hepatocytes,
but not endothelial cells (Fig. 2e). Furthermore, we confirmed the
uptake of TW295 by hepatocytes and other cells using ex vivo elec-
tron microscopic observation. As shown in Fig. 2f, there was uptake
of TW295 by Kupffer cells. This was not unexpected since Kupffer
cellsusuallyuptakebacteria.Interestingly,itwasobservedthathepa-
tocytesalsouptakeTW295(Fig.2g).Sincethemajorityofcellsinthe
liver are hepatocytes, these results clearly indicate that the localized
TW295 was mainly uptaken by hepatocytes.
Interestingly, increases in plasma alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) levels were observed in
TW295-administered mice 24 hours after infection (Supplementary
Fig. S2a). However, the increase was transient: the increased ALT and
AST levels returned to base levels similar to those of control mice on
day 9 (Supplementary Fig. S2b). In addition, visible tissue damage
to the liver was not observed in TW295-administered mice
(SupplementaryFig.S2c).Since the TW295-administered micebegan
to die on day 8—10 (Fig. 1c), this indicates that the cause of death in
TW295-administered mice was not due to direct liver toxicity.
Transient localization of TW295 in the liver may trigger unknown
pathways in the aggravation of colitis.
Target molecules involved in localization of TW295 in the liver.
We considered why only TW295, not MT8148, can survive in the
blood circulation, reach the liver, and beuptaken by hepatocytes. An
important difference between TW295 and MT8148 is that of
serotype. Therefore, we focused on the surface glucose side chains
thatdefinetheserotypeofS. mutans.Itisbelievedthatthedifference
in these surface glucose side chains plays arole in the phagocytosis
17.
The phagocytosis rate of TW295 by polymorphonuclear leukocytes
(PMNs) is much lower than that of MT8148, the standard strain
(Fig. 3a). To confirm the effect of the glucose side chains, we
prepared an isogenic mutant strain of MT8148 with a glucose
defection in the side chains (MT8148GD); the mutant strain had
similar glucose side chains to those of TW295 (serotype k). As
shown in Fig. 3a, the phagocytosis rate of MT8148GD was lower
than that of MT8148. In addition, MT8148GD showed the high
survivability in blood circulation like TW295 in vivo (Supplementary
Fig. S3). These results indicate that glucose side chains of serotype
k-type S. mutans are involved in the survivability of TW295 type
strains that escape phagocytosis in the blood circulation, and are able
to reach the liver.
Next, we investigated the molecule involved in the adhesion and
uptake of TW295 by hepatocytes. Recently, a cell-surface 120-kDa
collagen-binding adhesin (CBP) was identified in S. mutans, and its
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 332 | DOI: 10.1038/srep00332 2Figure 1 | Aggravation of mouse colitis by TW295, a specific strain of S. mutans. (a) Intervention study design. Drinking water containing DSS was
administered from days 0 to 15. Bacteria were intravenously injected on day 4. (b) Disease activity index (DAI) on DSS-induced colitis mice 6 days after
administration of vehicle (Control), TW295, or MT8148. Each column represents the mean 6 standard error (SEM) from 12–18 different animals.
StatisticalsignificancewasdeterminedusingBonferroni’smethodafteranalysisofvariance(ANOVA).*p,0.05.(c)Time-coursechangeofsurvivalrate
during the experimental period. Kaplan-Meier analysis was carried out for statistics. TW295; p50.0134 versus control, and MT8148; p50.9399 versus
control,respectively.(d)Survivalrateonday15.Eachcolumnrepresentsthemeanfrom12–18differentanimals.**p,0.01,*p,0.05,respectively.(e)
Typical appearance of the whole animal and the colon in control and TW295-infected mice on day 10. (f) Typical microscopic images of the colon in
control and TW295-infected mice on day 10. Mucosal damage and infiltration of inflammatory cells were observed in TW295-infected mice. (g) & (h)
Dose-dependent effects of TW295-mediated aggravation of colitis. (g) DAI on day 10 and (h) survival rate on day 15. A dose-dependent increase in DAI
and decrease in survival rate were observed with TW295. Each column represents the mean from 12–18 different animals. Statistical significance was
determined using Bonferroni’s method after ANOVA. **p , 0.01, *p , 0.05, respectively. (i) Route-dependent effects of TW295-mediated aggravation
of colitis. TW295 was administered intravenously (i.v.) or orally (p.o.). Each column represents the mean from 12–18 different animals (*p , 0.05).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 332 | DOI: 10.1038/srep00332 3Figure 2 | InvestigationofrealtargetorgansofTW295-inducedaggravationofcolitis. (a)DetectionofinfectedbacteriainorgansbyPCR.WholeDNA
was extracted and the nested PCR method was performed. Each organ represents the results from two different animals. (b) Confirmation of viable
bacteriainlivertissue.Thetissuespecimenswerecutintosmallpiecesandsqueezed,theninoculatedontomitissalivaraisbacitracin(MSB)agarplates.(c)
Time-dependentlocalizationsofviablebacteriainlivertissues.Viablecellnumbersareexpressed ascolonyforming units(CFU)/mgtissueprotein. Each
point represents the mean 6 SEM from 3–5 different animals. (d) Immunohistochemical stainig of serotype k bacteria in the DSS mouse liver.
Arrowheads represent positive staining. (e) Localization of GFP-expressing TW295 in the mouse liver. Administered GFP-expressing TW295 were
uptakenbyhepatocytes,butnotbyendothelialcells.Left,lowmagnificationofcentralveinarea;right,highmagnification ofsmallbloodvessel.Theblue
areasrepresentnuclearstainingby4’6-diamino-2-phenylindole(DAPI).CV,centralvein;BV,bloodvessel.(f)UptakeofTW295byKupffercellsusingex
vivo electron microscopy. (g) Uptake of TW295 by hepatocytes using ex vivo electron microscopy. Arrowheads represent TW295 uptake by hepatocyte.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 332 | DOI: 10.1038/srep00332 4Figure 3 | TargetmoleculesinvolvedinlocalizationofTW295intheliver. (a)InvitrophagocytosisratesofvariousS.mutans.MT8148GDisanisogenic
mutantstrainofMT8148withdefectionofglucosefromthesidechains;ithassimilarglucosesidechainstoTW295(serotypek).Eachcolumnrepresents
the mean 6 SEM from 3 independent experiments. Statistical significance was determined using Student’s t-test. MT8148 versus MT8148GD; **p 5
0.0071,MT8148 versus TW295; *p50.0134, respectively. (b)Collagen-binding activity ofvarious strainsof S. mutans.The activity wasevaluated under
thefixedconditionof2 mgoftypeIcollagenand1x10
10bacterialcells.TheresultsforeachstrainareexpressedasapercentagebasedonTW871as100%.
TW295CND is a mutant strain from TW295 with a defect in the expression of CBP. Each column represents the mean 6 SEM from 3 independent
experiments. (c) Adhesion of TW295 or MT8148 to Huh-7 hepatocytes. Each column represents the mean 6 SEM from 6 independent experiments.
Statistical significance was determined using Student’s t-test. **p 5 0.00914. (d) Decrease in adherent cells of TW295CND, CBP-defect strain generated
from TW295, to Huh-7 hepatocytes. Each column represents the mean 6 SEM from 4 independent experiments. Statistical significancewas determined
usingStudent’st-test.MT8148versusTW295;*p50.0157,TW295versusTW295CND;*p50.0328,respectively.(e)DAIofTW295CND-administered
mice and other S. mutans strains. Each column represents the mean 6 SEM from 12–18 different animals. Statistical significance was determined using
Bonferroni’s method after ANOVA. *p , 0.05. (f) Survival rate of TW295-administered mice and other S. mutans strains. Each column represents the
mean from 12–18 different animals (**p , 0.01).
www.nature.com/scientificreports
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22. Interestingly, TW295 has
this protein, and the collagen-binding activity of TW295 is dramat-
ically higher than that of MT8148 (Fig. 3b). In addition, adhesion of
TW295 to a Huh-7 hepatocyte, hepatocarcinoma-cell line, was sig-
nificantly higher than with MT8148 (Fig. 3c). These results indicate
that CBP of TW295 is involved in the adhesion to hepatocytes.
Therefore, we generated an isogenic mutant strain of TW295 with
a defect in the expression of CBP (TW295CND)
23. Like MT8148,
TW295CND was completely without the ability to bind collagen
(Fig. 3b), and it showed lower adherent ability with Huh-7 hepato-
cytes (Fig. 3d). We administered the TW295CND strain to the DSS-
inducedmousecolitismodel.AdrasticreductioninDAIandmarked
recovery of survival rate were observed in TW295CND-adminis-
tered mice compared with TW295-administered animals (Fig. 3e,
f). These results clearly indicate that cell-surface CBP is important
for adhesion to hepatocytes, resulting in colitis aggravation.
Incontrast,MT8148GDshowedatendency,butnotsignificant,to
aggravate the colitis (Fig. 3e, f). Although MT8148GD acquired high
survivability in blood circulation (Supplementary Fig. S3), the accu-
mulationofMT8148GDinliverwasmuchlowerthanthatofTW295
(Supplementary Fig. S4). These results indicate that both CBP and
specificglucosesidechainareimportantfortheaccumulationinliver
and colitis aggravation.
TW295-mediated increase in cytokine production. To investigate
the upper stream of amplification molecules in the inflammatory
response, we examined inflammatory cytokine expression in the
TW295-administered mouse liver. As shown in Fig. 4a, admini-
stration of TW295 to both DSS-induced colitis mice and normal
controls caused increased expressions of IFN-c in liver tissues.
However, no marked alterations were observed in the expression
of other inflammatory cytokines, such as TNF-a and IL-6
(Supplementary Fig. S5). In contrast, administration of the CBP-
deficient strain, TW295CND, did not produce an increase of IFN-
cintheliver(Fig.4a).Toconfirmtheresultsofthepolymerasechain
reaction (PCR) in tissues, immunohistochemical staining was
performed for IFN-c. As shown in Fig. 4b, increased expression of
IFN-cwasobservedintheliverandcolon.Theseresultsindicatethat
the release of IFN-c by the liver in TW295 infection may be the first
step in the onset of the inflammatory cascade producing various
inflammatory-related molecules.
To confirm the results observed in the in vivo colitis model, we
performed an in vitro cultured cell experiment. In contrast to
MT8148, TW295-applied Huh-7 hepatocarcinoma cell lines showed
increased expression of IFN-c (Fig. 4c). Furthermore, we used
human primary hepatocytes to confirm the results of Huh-7 and
found that TW295-treated human hepatocytes showed increased
expression of IFN-c (Fig. 4d). These results suggest that release of
IFN-c from TW295-applied hepatocytes is the real trigger of the
inflammatory cascade.
In addition, to confirm the further evidence that the TW295-
mediated release of IFN-c from hepatocytes is the real trigger of
the inflammatory cascade in vivo model, we administered anti-
IFN-c antibody to TW295-infected colitis mice. The administration
of anti-IFN-c antibody dramatically suppressed TW295-mediated
aggravation of colitis in comparison to no antibody administration
group in vivo model (Fig. 4e, f). These results clearly prove that the
TW295-mediated release of IFN-cfromliver isthe realtrigger of the
inflammatorycascadeinoralbacteria-inducedaggravation ofcolitis.
Detection and isolation of TW295-type S. mutans strains from
IBD patients. To further support our hypothesis that infection by
TW295-typeS.mutansisapotentialriskfactorincolitisaggravation,
we compared the frequency of TW295-type S. mutans between IBD
patients (Supplementary Tables S1, S2) and non-IBD healthy
subjects using oral samples. The characteristics of TW295-type S.
mutans are the existence of CBP and specific glucose side chains,
both of them are closely related to the effects of TW295-induced
colitis aggravation. As shown in Fig. 5a, the detection frequency of
the CBP-encoding cnm gene expressing S. mutans was higher in UC
patients than in healthy subjects (odds ratio, 1.72). Furthermore, it
has been reported that two minor serotype-specific glucose side
chains are involved in escape from phagocytosis, serotypes k and
f
17. Both serotypes are generally very rare (2.3% 1 3.5% 5 5.8%) in
healthy subjects compared with major serotypes, such as serotypes c
and e (Fig. 5b, left). In contrast, the detection frequency of both
serotypes k and f was significantly higher (12.5% 1 12.5% 5
25.0%) in UC patients than in healthy subjects (Fig. 5b). We also
calculated the frequency of specific strains of S. mutans that have
both the cnm gene and a specific serotype (k or f) between UC
patients and healthy subjects. As shown in Fig. 5c, the detection
frequency of such specific strains of S. mutans in UC patients was
dramatically higher than in healthy subjects (14.29% vs. 3.53%,
respectively; p50.0012; odds ratio, 4.55; 95% confidence interval,
1.87—11.09). These results may indicate that infection of such
specific strains of S. mutans that have both the cnm gene and a
specific serotype (korf) mayaffect aggravation of the UCpathology.
To confirm our observations, we tested the virulent effect of the
Cnm-expressingandserotypekorftypeofS.mutansstrainsisolated
from IBD patients. We tested two CBP-expressing S. mutans strains
from IBD patients (Sm-IBD8, serotype k; and Sm-IBD21, serotype f)
in the DSS-colitis model, since they showed the expression of CBP
and comparatively strong collagen-binding activity. Aggravation of
colitis, evident in the increase in DAI and decrease in survival rates,
was observed in mice administered with the two isolated CBP-
expressing specific S. mutans strains compared with controls
(Fig.6).Theseresultsclearlyindicatethatinfectionofspecificstrains
of TW295-type S. mutans is a risk factor in colitis aggravation.
Discussion
In the present study, we clearly showed that infection of specific
strains of S. mutans is one of the risk factors in aggravating inflam-
mation of UC. This is the first report describing the involvement of
oral bacteria in UC pathology.
Oral bacteria-related aggravation of colitis was clearly demon-
strated in the mouse colitis model infected with serotype k and the
CBP-expressing S. mutans strain, TW295. In addition, administered
bacteria were detected in the liver, but not in the colon and small
intestine, indicating that the interaction of serotype k and CBP-
expressing S. mutans with hepatocytes is a crucial event in the
developmentofcolitisinflammation.Thesespecificstrainsexhibited
common cell-surface conditions, such as expression of CBP and
specific glucose side chains that define the bacterial serotypes. Our
hypothesis is that both CBP and specific serotypes of k or f on S.
mutans are necessary for colitis aggravation. Such hypothesis is sup-
ported by our results that the CBP-defective mutant strain,
TW295CND, produced no aggravation of colitis and that the iso-
genicmutantstrainofMT8148withdefectionofglucosesidechains,
MT8148GD, escaped phagocytosis, required high survivability in
circulation and showed the tendency of colitis aggravation. These
specific characteristics of TW295 enabled it to reach the liver and
adhere to hepatocytes, resulting in the invasion into hepatocytes. In
fact, we have proposed direct evidence of uptake of oral bacteria by
hepatocytes. This is the first report about the uptake of infected oral
bacteria by hepatocytes. Since the majority of liver cells are hepato-
cytes, uptake of TW295 by hepatocytes may be the most important
step in causing the aggravation of further inflammatory responses.
Although the survivability of the specific strains of S. mutans in the
bloodcirculationmaybeduetocharacteristicsofglucosesidechains,
it is unclear what mechanisms and molecules are involved in adher-
ence to and uptake by hepatocytes. At least, our results presented
here indicate that CBP-related molecule(s) or mechanism(s) are
involved in the uptake of TW295-type oral bacteria by hepatocytes.
www.nature.com/scientificreports
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mutans may activate the hepatocytes themselves, because both cul-
tured hepatocytes and liver tissues generated IFN-c upon bacterial
stimulation. In general, IFN-c is produced by the liver in response
to bacterial and viral infection. However, the step of S. mutans-
mediated generation of IFN-c may trigger the inflammatory
reaction cascade to produce many other inflammatory molecules
that accelerate the further inflammation. These molecules, including
IFN-c,may beinitially generated fromhepatocytes and Kupffercells
and finally reach the colon to aggravate the inflammation of colitis
(Supplementary Fig. S6). In fact, the administration of anti-IFN-c
antibodyinvivodramaticallysuppressed TW295-mediatedaggrava-
tion of colitis. These results clearly prove that the TW295-mediated
releaseofIFN-cfromliveristheinitialtriggertocausetheactivation
Figure 4 | TW295-mediatedincreaseinIFN-cproductionsandeffectofanti-IFN-cantibodyonTW295-mediatedaggravationofcolitis. (a):Increased
expression of IFN-c in liver tissues after TW295 to mice with DSS-induced colitis and normal controls. Arrow indicates the size of IFN-c. GAPDH is an
internal standard for PCR. (b): Immunohistochemical staining of IFN-c in the liver and colon of mice after the administration of TW295 or vehicle
(Control).ThebrownareasrepresentpositiveexpressionofIFN-c.(c)&(d):IncreasedexpressionofIFN-conahepatocarcinomacellline,Huh-7(c)or
primary human hepatocytes (d) after the application of bacteria. Neg Con; negative control. GAPDH is an internal standard for PCR. (e): Effect of anti-
IFN-c antibody on DAI in TW295-infected DSS-induced colitis mice at 6 days after infection of TW295. The anti-IFN-c polyclonal antibody (0.5 mg/
mouse) was intraperitoneally administered mice at 4 and 24 hours after the TW295 infection. Each column represents the mean 6 SEM from 10–18
different animals. Statistical significance was determined using Student’s t-test. **p 5 0.0099. (f): Effect of anti-IFN-c antibody on survival rate in
TW295-infectedDSS-inducedcolitismiceat11daysafterinfectionofTW295.Theanti-IFN-cpolyclonalantibody(0.5 mg/mouse)wasintraperitoneally
administered mice at 4 and 24 hours after the TW295 infection. Each column represents the mean from 10–18 different animals. Statistical significance
was determined using Student’s t-test. **p 5 0.0059.
www.nature.com/scientificreports
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colitis.We,therefore,hypothesizethefollowingmechanisticscheme.
After the invasion of specific types of S. mutans, they escape pha-
gocytosis through their specific glucose side chains and survive for a
long time in the blood circulation. Immune cells may be unable to
recognize the structures of such specific glucose side chains as bac-
teria.Afterthejourney toliver, thespecific typesofS.mutans adhere
to and invade hepatocytes by expression of CBP. Then, bacteria-
stimulated hepatocytes generate IFN-c following the release of
various inflammatory molecules. Such molecules reach the colon
resulting in acceleration of the inflammatory response to aggravate
colitis(SupplementaryFig.S6).Thisapproachoforalbacteriaisfrom
theinsideofbloodcirculation,butnotfromthemucosaofthelumen
side of the gastrointestinal tract, because oral administration of
TW295 did not produce colitis aggravation. Our results support this
novel concept about oral bacteria-mediated aggravation of colitis.
It is unknown why hepatocytes passively uptake such specific types
of S. mutans. One possibility is a final exclusion mechanism for dan-
gerous bacteria as a protection against bacteremia, because such spe-
cific strains of bacteria have already broken through the intrinsic
Figure 5 | Detectionand isolation ofTW295-type S.mutans strains from IBDpatients. (a) Detectionfrequency ofCBP-encoding cnmgene expressing
S. mutans in IBD patients and healthy subjects. Amomg 98 IBD patients, 56 were S. mutans positive (57.14%). (b) Detection frequency of various
serotypes.Serotypekandfareveryrare(2.3%13.5%55.8%)inhealthysubjectscompared withmajorserotypes,suchasserotypes cande.Incontrast,
the detection frequency of serotype k and f was dramatically higher (12.5% 1 12.5% 5 25.0%) than with serotypes c and e. (c) The frequency of specific
strains of S. mutans that have both the cnm gene and a specific serotype (k or f) in IBD patients and healthy subjects. The detection frequency of such
specific strains of S. mutans in IBD patients was dramatically higher than in healthy subjects (14.29% vs. 3.53%, respectively; odds ratio, 4.55, 95%;
confidence interval, 1.87–11.09; p50.0012).
www.nature.com/scientificreports
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tioned how so many bacteria can easily invade the blood circulation
from the oral mucosa through dental procedures. Previous reports
indicated that bacteremia can easily occur through such dental pro-
cedures as tooth brushing and extraction
14,15. In addition, the aggrava-
tion by TW295 was observed with only 10
4 bacterial cells. Such cell
numbers are easily achievable with ordinary dental procedures
14,15.
The rate of oral cavity infection byspecific typesof S. mutanswith
CBP in healthy subjects was 12.5%. In addition, the detection fre-
quencyofspecificserotypesofS.mutans(kandf)was2.3%and3.5%,
respectively. Thus, in normal situations, only a limited number of
strains are possible risk factors for aggravation of UC caused by S.
mutans-induced bacteremia. In contrast, the detection frequency of
specific strains of S. mutans,such as CBP-positiveand phagocytosis-
resistantstrainsfromUCpatients,wasextremelyhigherthaninnon-
UC control subjects (p50.0012; odds ratio, 4.55). These results indi-
catethatbacteremiawithhighlyvirulentTW295-typeS.mutansmay
be an important risk factor for aggravation of colitis in many clinical
cases. In addition, we showed that several S. mutans strains isolated
from UC patients caused aggravation of colitis in a mouse DSS
model, indicating the potential involvement of highly virulent S.
mutans in occurrences of UC. These results clearly suggest that
infection by highly virulent S. mutans is, in part, involved in the
aggravation or occurrence of UC. It has been reported that admin-
istration of antibiotics shows amelioration of IBD symptoms in
patients
9. This report may partially support our hypothesis.
Further large-scale clinical-screening investigations about the rela-
tionship between the infection of highly virulent S. mutans and the
occurrence of IBD are required.
In conclusion, infection with highly virulent specific types of S.
mutans is a potential risk factor for UC. The important identified
virulencefactorsfortheaggravationofcolitisarethepresenceofCBP
and the lack of surface glucose side chains. This is the first report
describing the involvement of oral bacteria in IBD pathology.
Figure 6 | Specific strains of S. mutans isolated from IBD patients aggravate the colitis. (a) Typical photos of whole mice administered isolated S.
mutans. Sm-IBD 8 was isolated from patient 8 and Sm-IBD 21 from patient 21 in Supplementary Table 2. (b) Typical microscopic image of the colon of
Sm-IBD8-infectedmiceonday10.MucosaldamageandinfiltrationofinflammatorycellswereobservedinSm-IBD8-infectedmice.(c)DAIofisolatedS.
mutans strains from IBD patients. Each column represents the mean 6 SEM from 10–12 different animals. Statistical significance was determined using
Bonferroni’s method after ANOVA. *p , 0.05. (d) Survival rate of isolated S. mutans strains from IBD patients. Each column represents the mean from
10–12 different animals.
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Reagents and antibodies. Dextran sodium sulfate (DSS; molecular weight, 36,000—
50,000) was purchased from MP Biomedicals, LLC (Solon, OH, USA). Anti-
interferon gamma (IFN-c) polyclonal antibody was purchased from BioLegend (San
Diego, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other
chemicals were of reagent grade.
Bacterial strains and culture condition. MT8148, the standard strain of S. mutans
(serotype c) isolated from the oral cavity of a healthy child, and TW295, a serotype k
strainisolatedfrom asubjectwith bacteremiaafter toothextraction,wereusedin this
study
17–19,24. In addition, two isolated clinical S. mutans strains (Sm-IBD 8 and Sm-
IBD 21) from oral samples of IBD patients were used in this study. We also used
mutant strains, TW295CND derived from TW295, and MT8148GD derived from
MT8148 to investigate the mechanism. Namely, TW295CND is an isogenic mutant
strainof TW295with insertional inactivation with anerythromycin-resistant gene in
the middle of cnm encoding collagen-binding protein (CBP)
23. MT8148GD is a
glucose side chain-defective mutant strain of MT8148 constructed by inactivation of
the gene encoding the enzyme for biosynthesis of the glucose side chain by an
erythromycin-resistant gene
17. Furthermore, we prepared green-fluorescent protein
(GFP)-expressing TW295 and used it in this study
21. All strains were grown in brain
heart infusion (BHI) broth (Difco Laboratories, Detroit, MI, USA) as well as on mitis
salivarius agar with bacitracin (MSB, 100 U/ml; Sigma-Aldrich, St.Louis, MO, USA)
and 15% sucrose (MSB agar).
DSS-induced mouse colitis model and administration of S. mutans to mice. All
miceweretreated humanely inaccordance with theNational InstitutesofHealth and
AERI-BBRI Animal Care and Use Committee guidelines. All animal experiments
were approved by the institutional animal care and use committee of Osaka
University Graduate School of Dentistry. DSS-induced colitis model was performed
according to the method previously described
25,26. Specific pathogen free, male
C57BL/6J mice were purchased from CLEA Japan (Shizuoka, Japan). Colitis was
induced in 7-week-old mice (weighing 20–25 g) with 2.5% (w/v) DSS in the drinking
water ad libitum which results in clinical symptoms of UC after 4 days and
perforation of the gut and death at approximately 10–15 days
25,26.
Bacterial suspensions in phosphate-buffered saline (PBS) were intravenously
administered viathe jugular vein(10
3–10
7cells/body) onday4 after the onsetofDSS-
colitis (Fig. 1a). Mice were weighed and visually inspected for diarrhea and rectal
bleeding after induction of colitis. Then, an average disease activity index (DAI),
including such signs as diarrhea and bleeding was calculated based on data collected
by double-blinded observers according to a scoring method, as previously
described
25,26. Survival rates of the mice were also recorded.
To investigate the role of IFN-c on TW295-mediated aggravation of colitis, anti-
IFN-c polyclonal antibody (0.5 mg/mouse) was intraperitoneally administered mice
at 4 and 24 hours after the TW295 infection. The DAI and survival rate were
evaluated.
Histologicalanalysisandimmunohistochemical staining.Forhistologicalanalysis,
tissue samples were fixed in 3.7% formaldehyde-PBS, embedded in paraffin, and 3-
micrometersectionswerestainedwithhematoxylin-eosin(H&E).AlterationsofIFN-
c expression in the tissues were detected using standard immunohistochemical
techniques with each antibody. The vectastain ABC kit (Vector Laboratories,
Burlingame, CA) was used with the 3, 3'-diaminobenzidine substrate kit (Vector
Laboratories),accordingtothemanufacturer'sinstructions,aspreviouslydescribed
26.
Detection of bacteria in tissue samples. The colon, small intestine, liver, and lung
were extirpated from the mice after the injection of 1x10
7 colony formation units
(CFU)ofS.mutansTW295intothejugularvein.Detectionoftheinfectingbacteriain
the organs was carried out by PCR as follows. Whole DNA was extracted from the
extirpatedtissues,andPCRwascarriedoutusingS.mutans-specificsetsofprimers,as
described previously
17. The nested PCR method was also performed to determine
positive reactions.
To confirm that viable strains were in the tissue, tissue specimens were cut into
small pieces and squeezed; this was then inoculated onto MSB agar plates and
anaerobically incubated at 37uC for 48 hours. These were used as the culture agar
plates for S. mutans. The number of bacterial colonies was counted by visual
inspection of the agar plates.
Phagocytosis assay. Phagocytosis assay was performed as described previously
17.
Briefly, the tested organisms were cultured in BHI for 18 hours at 37uC. After the
bacterial cells were washed, the cell concentrations were adjusted with PBS to
1.0x10
8 CFU/ml. Human peripheral blood (500 ml) was collected from a healthy
volunteer and incubated with 500 ml (5.0x10
7 CFU) of the tested bacteria for 10 min
at 37uC. Interactions between polymorphonuclear leukocytes (PMNs) and bacteria
were observed using a light microscope (magnification, x100; Olympus Optical,
Tokyo, Japan)following Giemsa staining(Wako Pure Chemicals, Osaka,Japan). The
rate of phagocytosis was expressed as the mean ratio of phagocytosed PMNs per
100 PMNs, with 500 PMNs being examined. Data are expressed as the mean 6
standard errors of triplicate experiments.
Collagen-binding assay. The collagen-binding properties of mutants and parent
strains were evaluated according to the method described by Waterhouse and
Russell
27, with some modifications as described previously
28. The results for each
strain are expressed as a percentage compared with TW871 binding, which was
defined as 100%.
Bacterial adhesion assay. Adhesion of bacteria onto hepatic cells was investigated as
follows. Approximately 1x10
5 Huh-7 cells were seeded in parallel wells of 6-well
tissue-culture plates. Prior to infection, the wells were washed 3 times with PBS, then
antibiotic-free medium was added. Huh-7 cells were infected by the addition of
1x10
8 CFU of strains TW295 and MT8148. After 15 and 30 minutes of aerobic
incubation,themediumwasremovedandtheinfectedcellswerewashed3timeswith
PBS. To test for adherence, 1.0 ml of sterile distilled water was added and the cells
were allowed to burst. Dilutions of the cell lysate infected with S. mutans were plated
on MSB agar and cultured at 37uC for 48 hours in an anaerobic condition. The
number of adherent bacteria was determined and expressed as the mean 6 standard
errors of triplicate experiments.
Quantitative RT-PCR for detection of cytokine mRNA. Quantification of mRNA
encoding for TNF-a, IL-6, and IFN-c in the tissues after the administration of S.
mutans was conducted using an RT-PCR system. Briefly, tissue specimens were
extirpated 24 hours after infection of 1x10
7 CFU of S. mutans TW295 via the jugular
vein.Forreversetranscription-PCR(RT-PCR),totalRNAwaspreparedusingtheSV
Total RNA Isokation System (Promega), and total RNA was reversed transcribed by
using the High-capacity cDNA Reverse Transcription kit (Applied Biosystems)
according to the manufacturer's instructions. The primer information is described in
Supplementary Table S3. Messenger RNA expression of TNF-a, IL-6, and IFN-c in
the tissues was determined. Data were normalized using GAPDH as an internal
standard.
In the case of cultured cells, S. mutans TW295 strains (1x10
8 CFU) were added to
Huh-7 cells (1310
5 cells/well) in a 6-well culture plate, and the cultures were incu-
bated at 37uCi n5 %C O 2 for 5 hours. RT-PCR was performed by the method
described above. In addition, we used primary hepatocytes isolated from a normal
human liver (Lonza Walkersville,Inc., MD) to confirm the results with the Huh-7
cells.
Ethics regarding human subjects. Study protocols in humans were approved by the
Ethics Committee of Yokohama City University School of Medicine and Osaka
University Graduate School of Dentistry.
All subjects were informed of the protocols and gave their written consent prior to
participating in the study. Oral samples were collected from Yokohama City
University Hospital and Osaka University Dental Hospital. A summary and detailed
information of the IBD patients are presented in Supplementary Tables S1 and S2.
Non-IBD subjects who did not have a history of any other disease, such as IBD, heart
failure, rheumatoid arthritis, and kidney disease, were defined as control subjects.
Detection of bacteria in the oral samples was performed according to the method
described previously
17.
Statistical analysis. All results are expressed as means 6 standard errors (SEM) or
standard deviation (SD). Fisher's protected least-significant difference test, Student's
t-test, Bonferroni's method after analysis of variance (ANOVA), regression analysis
andKaplan-Meieranalysiswerecarriedout.Theresultswereconsideredsignificantly
different at p , 0.05.
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